Intellia Therapeutics, Inc. (NTLA)
14.26
+0.77
(+5.71%)
USD |
NASDAQ |
Apr 13, 16:00
14.34
+0.08
(+0.56%)
After-Hours: 20:00
Intellia Therapeutics Cash from Investing (TTM) : 228.03M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | -16.87M |
| Personalis, Inc. | -22.57M |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Novavax, Inc. | -78.27M |
| KalVista Pharmaceuticals, Inc. | -- |